INTERVENTIONAL FLASHLIGHT

DOI: 10.4244/EIJ-D-17-00637

Percutaneous biventricular cardiac assist device in cardiogenic shock and refractory cardiac arrest

Julia Ellert1*, MD; Margrethe Jermiin Jensen2, MD; Lisette Okkels Jensen1, MD, DMSci, PhD; Jacob Eifer Møller1, MD, DMSci, PhD

A 65-year-old man was admitted to our catheterisation laboratory after 55 minutes of cardiopulmonary resuscitation (CPR) due to refractory out-of-hospital cardiac arrest (OHCA). The initial rhythm was ventricular fibrillation which after defibrillation converted to pulseless electrical activity. The patient had a history of intermittent claudication. Immediately upon arrival, establishment of mechanical support was evaluated, in order to achieve return of spontaneous circulation. Usually, this will be achieved by using venoarterial extracorporeal membrane oxygenation (VA-ECMO)1. A previous small study suggested that mechanical support of the left ventricle (LV) with the microaxial Impella® CP pump (Abiomed, Danvers, MA, USA) may be feasible in this setting2. The Heart Team decided to implant an Impella CP in an attempt to re-establish circulation and perform coronary angiography. After insertion of the Impella CP, restoration of circulation was achieved after a total of 74 minutes with CPR (Moving image 1). A subsequent coronary angiogram showed a chronic occlusion of the proximal left anterior descending artery (Panel A) and an acute occlusion of the proximal right coronary artery (RCA) (Panel B). Percutaneous coronary intervention (PCI) with implantation of one drug-eluting stent in the RCA was performed (Panel C). Despite initial stabilisation, shortly after PCI the patient developed right ventricular (RV) failure that was not responsive to intravascular volume optimisation, high-dose inotropes and transvenous pacing (Moving image 2). In the current case, VA-ECMO could be considered as an alternative in such a situation3. Support using the percutaneous right ventricular-assist device Impella RP has previously been shown to be safe in patients with adequate oxygenation and RV failure, resulting in immediate haemodynamic improvement4, and thus seemed to be a valuable option in this situation.

After implantation of an Impella RP (Panel D), the patient was transferred to the intensive care unit, where circulatory stabilisation was achieved. Echocardiography on day 6 showed improvement of the RV function whereas the LV function was still reduced (ejection fraction 20%) (Panel E1, Panel E2, Moving image 3). The Impella RP could be removed on day 7 and the Impella CP on day 8. There were no device-related complications. The patient could be extubated on day 12 of his hospital stay without any neurological deficits and discharged home on day 41. Twelve months after the index event he was in good condition without further clinical events.

These images describe the first case of successful treatment of refractory OHCA and cardiogenic shock with biventricular failure by using biventricular Impella support.

Conflict of interest statement

L. Okkels Jensen has received research grants from Biotronik, St. Jude Medical, and Biosensors to her institution. The other authors have no conflicts of interest to declare.

Supplementary data

Moving image 1. Transoesophageal echocardiography after implantation of the Impella CP.

Moving image 2. Transoesophageal echocardiography showing a dilated right ventricle with a shift of the interventricular septum towards the left ventricle.

Moving image 3. Transthoracic echocardiography on day 6.

Supplementary data

To read the full content of this article, please download the PDF.

Moving image 1. Transoesophageal echocardiography after implantation of the Impella CP.

Moving image 2. Transoesophageal echocardiography showing a dilated right ventricle with a shift of the interventricular septum towards the left ventricle.

Moving image 3. Transthoracic echocardiography on day 6.

Volume 13 Number 18
Apr 6, 2018
Volume 13 Number 18
View full issue


Key metrics

Suggested by Cory

10.4244/EIJV13I18A344 Apr 6, 2018
Mechanical circulatory support: the last resort in cardiogenic shock?
Thiele H et al
free

Image – Interventional flashlight

10.4244/EIJ-D-19-00942 Feb 5, 2021
Entrapment of the Impella heart pump in the mitral subvalvular apparatus
Khalid N et al
free

10.4244/EIJ-D-19-00279L Oct 18, 2019
Impella device use in high-risk PCI
Chhabra L et al
free

EXPERIMENTAL RESEARCH

10.4244/EIJ-D-18-00684 Feb 7, 2019
Impella CP or VA-ECMO in profound cardiogenic shock: left ventricular unloading and organ perfusion in a large animal model
Moller-Helgestad OK et al
free

CLINICAL RESEARCH

10.4244/EIJ-D-17-01014 Apr 6, 2018
Outcome after revascularisation of acute myocardial infarction with cardiogenic shock on extracorporeal life support
Overtchouk P et al
free
Trending articles
151.43

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
55.9

Clinical research

10.4244/EIJ-D-22-00621 Feb 20, 2023
Long-term changes in coronary physiology after aortic valve replacement
Sabbah M et al
free
54.9

Expert review

10.4244/EIJ-D-21-01010 Jun 24, 2022
Device-related thrombus following left atrial appendage occlusion
Simard T et al
free
43.75

Clinical Research

10.4244/EIJ-D-21-01091 Aug 5, 2022
Lifetime management of patients with symptomatic severe aortic stenosis: a computed tomography simulation study
Medranda G et al
free
39.95

Clinical research

10.4244/EIJ-D-22-00558 Feb 6, 2023
Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis
Pellegrini C et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved